
Loading, please wait...

Loading, please wait...

The Syrian hamster (Mesocricetus auratus) serves as a critical animal model for human infectious diseases. Because they exhibit similar disease progression and immune responses to humans, they are especially useful for studying respiratory tract infections. However, researchers have faced challenges because the genomic characterization of hamster B and T cell receptor loci remained incomplete. Consequently, a new study has revolutionized Syrian hamster immune profiling by establishing a robust reference set for immunoglobulin (IG) and T cell receptor (TR) sequences.
The research team performed long-read transcriptome sequencing across six different tissue types. This process yielded 43,090 full-length IG/TR transcripts, which allowed the construction of a reference set containing 22 IG/TR constant (C) regions. Furthermore, the scientists validated this reference using independent single-cell transcriptome datasets. Interestingly, allelic variations appeared in only two subclasses: IGHE and TRBC1. While IGHE produced a synonymous variant, TRBC1 resulted in a non-synonymous variant (S71G) with minimal predicted impact on protein structure. Therefore, these resources provide an unprecedented level of accuracy for future immunological studies.
In addition to characterization, the team designed and experimentally validated species-specific primers. These primers target the IG/TR C regions, making them essential tools for high-throughput immune repertoire analysis. As a result, researchers can now capture the full diversity of the hamster immune response more comprehensively. This development is particularly significant for the evaluation of vaccines and therapeutics against respiratory pathogens such as COVID-19 and influenza.
Syrian hamsters are preferred because their disease progression and immune responses closely mirror those of humans, particularly in the context of respiratory infections like COVID-19 and influenza.
The new primers allow for precise and comprehensive immune repertoire profiling. This enables scientists to track how B and T cells respond to infections or vaccinations with much higher resolution than previously possible.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New genomic resources for Syrian hamsters will enable better immune profiling in models of human respiratory infections like COVID-19 and influenza....
5 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today